Nikang Therapeutics
Wilmington, United States · Founded 2017 · $260.0M raised
- Headquarters
- Wilmington, Delaware
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- nikangtx.com
- Total Funding
- $260.0M
- Last Round
- $200.0M Series CMay 2021
- Rounds
- 3
About
Clinical-stage biotech company developing innovative small molecule oncology drugs.
Summary
Nikang Therapeutics is a Biotech company based in Wilmington, United States, founded in 2017. It has raised $260.0M in total across 3 rounds, most recently a $200.0M Series C round in May 2021. Investors include RTW Investments, Cormorant Asset Management and EcoR1 Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
May 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company